Timothy W. Brotherton, PhD, MD
Timothy W. Brotherton, PhD, MD
Dr. Brotherton graduated from The Johns Hopkins University in 1975 with a BA in Biophysics. He went on to earn a Ph.D. in Developmental and Molecular Biology from McMaster University in Hamilton, Ontario in 1978. He attended medical school at the University of Iowa College of Medicine from 1978 to 1982; graduated first in his class and elected to Alpha Omega Alpha, the national medical honor society. Dr. Brotherton was also distinguished by being the recipient of Research Fellowships which allowed him to continue his work in the Department of Biochemistry throughout medical school and subsequent training. Dr. Brotherton remained at the University of Iowa for residency training in Internal Medicine, and for his fellowship in Hematology and Oncology (1985-1987); he also served as Chief Resident in Internal Medicine. From 1987 to 1991, Dr. Brotherton was a member of the Faculty of the Department of Internal Medicine at the University of Iowa, with joint responsibility as Research Associate at the Veterans Administration Medical Center in Iowa City. He was the recipient of numerous prestigious awards and research grants which resulted in the publication of over 25 peer-reviewed journal articles and book chapters reporting the results of his investigations of the regulation of gene expression and molecular hematology. Dr. Brotherton joined the staff at Danville Hematology and Oncology in 1991.
Danville Hematology & Oncology has served patients throughout Danville, Pittsylvania County and surrounding areas more than 25 years. We are a full service cancer center offering advanced level of diagnosis and treatment to our patients whether they have a blood disorder, cancer or other disease. Our office provides on-site chemotherapy, laboratory testing and participation in nationally recognized clinical trials.
Danville Hematology & Oncology is a member of the Southeast Cancer Control Consortium (SCCC), a National Cancer Institute sponsored Community Clinical Oncology Program. This membership allows access to the most current national clinical trials. The SCCC has 24 institutions in 18 communities in a five-state area. With this membership, Danville Hematology & Oncology is allowed to participate in research with the following groups: Cancer and Leukemia Group B (CALGB), Southwest Oncology Group (SWOG), National Surgical Adjuvant Breast and Bowel Project (NSABP), Cancer Trials Support Unit (CTSU), provides an affiliation with the North Central Cancer Treatment Group (NCCTG), Gynecologic Oncology Group (GOG), Eastern Cooperative Oncology Group (ECOG), and the American College of Surgeons Oncology Group (ASCSOG).
Outside the membership with the SCCC, Danville Hematology & Oncology also conducts research with Wake Forest University Baptist Medical Center Comprehensive Cancer Center, Virginia Commonwealth University and the private pharmaceutical industry.
Danville Hematology & Oncology offers immediate lab results through our on-site facility. Our laboratory is CLIA (Clinical Laboratory Improvement Amendment) and COLA (Commission on Office Laboratory Accreditation) certified. Our advanced clinical laboratory equipment allows processing of hematology, clinical chemistries, immunodiagnostics, coagulation and urinalysis.
Medical Education & Training
Medical School: University of Iowa College of Medicine
Residency: Internal Medicine, University of Iowa College of Medicine
Fellowship: Hematology and Oncology, University of Iowa College of Medicine
Specialty Board Certifications: Board Certified in Hematology, Board Certified in Oncology and Board Certified in Internal Medicine
Dr. Brotherton is an active member of the Southeast Cancer Control Consortium, Piedmont Oncology Association and numerous other professional societies.
Danville Hematology & Oncology participates with most insurance companies including Medicare and Medicaid.